BTG3 and autoimmune disease: Such a “primed” immune environment may theoretically have facilitated a pathological response to the vaccine-induced activation of the dendritic cells and T-helper lymphocytes, although no specific autoimmune disease was diagnosed at that time and the weakly positive ANA remained of unclear significance.